Authors: Tunca, B Egeli, U Zorluoglu, A Yilmazlar, T Yerci, O Kizil, A

Citation: B. Tunca et al., The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives, CANCER LETT, 152(2), 2000, pp. 201-209

Authors: Tunca, B Egeli, U Zorluoglu, A Yilmazlar, T Yerci, O Kizil, A

Citation: B. Tunca et al., The expression frequency of common fragile sites and genetic predisposition to colon cancer, CANC GENET, 119(2), 2000, pp. 139-145

Authors: Gurel, S Dolar, E Yerci, O Samli, B Ozturk, H Nak, SG Gulten, M Memik, F

Citation: S. Gurel et al., The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer, J INT MED R, 27(2), 1999, pp. 74-78

Authors: Gurel, S Yerci, O Filiz, G Dolar, E Yilmazlar, T Nak, SG Gulten, M Zorluoglu, A Memik, F

Citation: S. Gurel et al., High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in turkey, J INT MED R, 27(2), 1999, pp. 79-84

Authors: Gurel, S Dolar, E Yerci, O Samli, B Ozturk, H Nak, SG Gulten, M Memik, F

Citation: S. Gurel et al., Expression of p53 protein and prognosis in gastric carcinoma, J INT MED R, 27(2), 1999, pp. 85-89

Authors: Orhan, B Yalcin, S Evrensel, T Yerci, O Manavoglu, O

Citation: B. Orhan et al., Successful treatment of cranial metastases of extrapulmonary small cell carcinoma with chemotherapy alone, MED ONCOL, 15(1), 1998, pp. 66-69